-
2
-
-
77956216718
-
Understanding latent tuberculosis: A moving target
-
P.L. Lin, and J.L. Flynn Understanding latent tuberculosis: a moving target J. Immunol. 185 2010 15 22
-
(2010)
J. Immunol.
, vol.185
, pp. 15-22
-
-
Lin, P.L.1
Flynn, J.L.2
-
3
-
-
84877267006
-
Advances in the development of new tuberculosis drugs and treatment regimens
-
A. Zumla, and et al. Advances in the development of new tuberculosis drugs and treatment regimens Nat. Rev. Drug Discov. 12 2013 388 404
-
(2013)
Nat. Rev. Drug Discov.
, vol.12
, pp. 388-404
-
-
Zumla, A.1
-
4
-
-
79955111092
-
Macrophages and control of granulomatous inflammation in tuberculosis
-
J.L. Flynn, and et al. Macrophages and control of granulomatous inflammation in tuberculosis Mucosal Immunol. 4 2011 271 278
-
(2011)
Mucosal Immunol.
, vol.4
, pp. 271-278
-
-
Flynn, J.L.1
-
5
-
-
84883668448
-
Modeling the Mycobacterium tuberculosis granuloma - The critical battlefield in host immunity and disease
-
E. Guirado, and L.S. Schlesinger Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease Front. Immunol. 4 2013 98
-
(2013)
Front. Immunol.
, vol.4
, pp. 98
-
-
Guirado, E.1
Schlesinger, L.S.2
-
6
-
-
84891853921
-
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
-
P.L. Lin, and et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing Nat. Med. 20 2014 75 79
-
(2014)
Nat. Med.
, vol.20
, pp. 75-79
-
-
Lin, P.L.1
-
7
-
-
6344281115
-
Identifying control mechanisms of granuloma formation during M. Tuberculosis infection using an agent-based model
-
J.L. Segovia-Juarez, and et al. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model J. Theor. Biol. 231 2004 357 376
-
(2004)
J. Theor. Biol.
, vol.231
, pp. 357-376
-
-
Segovia-Juarez, J.L.1
-
8
-
-
65449166781
-
Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection
-
J.C. Ray, and et al. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection J. Immunol. 182 2009 3706 3717
-
(2009)
J. Immunol.
, vol.182
, pp. 3706-3717
-
-
Ray, J.C.1
-
9
-
-
79953194081
-
Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation
-
M. Fallahi-Sichani, and et al. Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation J. Immunol. 186 2011 3472 3483
-
(2011)
J. Immunol.
, vol.186
, pp. 3472-3483
-
-
Fallahi-Sichani, M.1
-
10
-
-
84880273351
-
Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection
-
N.A. Cilfone, and et al. Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection PLoS ONE 8 2013 e68680
-
(2013)
PLoS ONE
, vol.8
, pp. e68680
-
-
Cilfone, N.A.1
-
11
-
-
77955478490
-
Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma
-
M. Fallahi-Sichani, and et al. Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma PLoS Comput. Biol. 6 2010 e1000778
-
(2010)
PLoS Comput. Biol.
, vol.6
, pp. e1000778
-
-
Fallahi-Sichani, M.1
-
12
-
-
84859377308
-
Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability
-
M. Fallahi-Sichani, and et al. Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability J. Immunol. 188 2012 3169 3178
-
(2012)
J. Immunol.
, vol.188
, pp. 3169-3178
-
-
Fallahi-Sichani, M.1
-
13
-
-
84866354551
-
NF-kappaB signaling dynamics play a key role in infection control in tuberculosis
-
M. Fallahi-Sichani, and et al. NF-kappaB signaling dynamics play a key role in infection control in tuberculosis Front. Physiol. 3 2012 170
-
(2012)
Front. Physiol.
, vol.3
, pp. 170
-
-
Fallahi-Sichani, M.1
-
14
-
-
33745622432
-
Early events in Mycobacterium tuberculosis infection in cynomolgus macaques
-
P.L. Lin, and et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques Infect. Immun. 74 2006 3790 3803
-
(2006)
Infect. Immun.
, vol.74
, pp. 3790-3803
-
-
Lin, P.L.1
-
15
-
-
80053931194
-
A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages
-
G. Magombedze, and N. Mulder A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages J. Theor. Biol. 292 2012 44 59
-
(2012)
J. Theor. Biol.
, vol.292
, pp. 44-59
-
-
Magombedze, G.1
Mulder, N.2
-
16
-
-
84857474188
-
Two-drug antimicrobial chemotherapy: A mathematical model and experiments with Mycobacterium marinum
-
P. Ankomah, and B.R. Levin Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum PLoS Pathog. 8 2012 e1002487
-
(2012)
PLoS Pathog.
, vol.8
, pp. e1002487
-
-
Ankomah, P.1
Levin, B.R.2
-
17
-
-
34548861262
-
GSMN-TB: A web-based genome-scale network model of Mycobacterium tuberculosis metabolism
-
D.J. Beste, and et al. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism Genome Biol. 8 2007 R89
-
(2007)
Genome Biol.
, vol.8
, pp. R89
-
-
Beste, D.J.1
-
18
-
-
84883173541
-
(13)C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis
-
D.J. Beste, and et al. (13)C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis Chem. Biol. 20 2013 1012 1021
-
(2013)
Chem. Biol.
, vol.20
, pp. 1012-1021
-
-
Beste, D.J.1
-
19
-
-
79960933284
-
(1)(3)C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation
-
D.J. Beste, and et al. (1)(3)C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation PLoS Pathog. 7 2011 e1002091
-
(2011)
PLoS Pathog.
, vol.7
, pp. e1002091
-
-
Beste, D.J.1
-
20
-
-
78649617204
-
Carbon flux rerouting during Mycobacterium tuberculosis growth arrest
-
L. Shi, and et al. Carbon flux rerouting during Mycobacterium tuberculosis growth arrest Mol. Microbiol. 78 2010 1199 1215
-
(2010)
Mol. Microbiol.
, vol.78
, pp. 1199-1215
-
-
Shi, L.1
-
21
-
-
34447317247
-
Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets
-
N. Jamshidi, and B.O. Palsson Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets BMC Syst. Biol. 1 2007 26
-
(2007)
BMC Syst. Biol.
, vol.1
, pp. 26
-
-
Jamshidi, N.1
Palsson, B.O.2
-
22
-
-
84866925914
-
Modeling phenotypic metabolic adaptations of Mycobacterium tuberculosis H37Rv under hypoxia
-
X. Fang, and et al. Modeling phenotypic metabolic adaptations of Mycobacterium tuberculosis H37Rv under hypoxia PLoS Comput. Biol. 8 2012 e1002688
-
(2012)
PLoS Comput. Biol.
, vol.8
, pp. e1002688
-
-
Fang, X.1
-
23
-
-
70449513046
-
A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis
-
X. Fang, and et al. A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis BMC Syst. Biol. 3 2009 92
-
(2009)
BMC Syst. Biol.
, vol.3
, pp. 92
-
-
Fang, X.1
-
24
-
-
79953209270
-
Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid
-
A.G. Bhat, and et al. Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid Syst. Synth. Biol. 4 2010 299 309
-
(2010)
Syst. Synth. Biol.
, vol.4
, pp. 299-309
-
-
Bhat, A.G.1
-
25
-
-
84876933802
-
Shifting from the single to the multitarget paradigm in drug discovery
-
J.L. Medina-Franco, and et al. Shifting from the single to the multitarget paradigm in drug discovery Drug Discovery Today 18 2013 495 501
-
(2013)
Drug Discovery Today
, vol.18
, pp. 495-501
-
-
Medina-Franco, J.L.1
-
26
-
-
84924184136
-
A systems biology approach for understanding granuloma formation and function in tuberculosis
-
J. McFadden, D.J.V. Beste, A.M. Kierzek, Springer
-
M. Fallahi-Sichani, and et al. A systems biology approach for understanding granuloma formation and function in tuberculosis J. McFadden, D.J.V. Beste, A.M. Kierzek, Systems biology of tuberculosis 2013 Springer
-
(2013)
Systems Biology of Tuberculosis
-
-
Fallahi-Sichani, M.1
-
27
-
-
45449094504
-
A methodology for performing global uncertainty and sensitivity analysis in systems biology
-
S. Marino, and et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology J. Theor. Biol. 254 2008 178 196
-
(2008)
J. Theor. Biol.
, vol.254
, pp. 178-196
-
-
Marino, S.1
-
28
-
-
35748953415
-
Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue
-
S. Marino, and et al. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue PLoS Comput. Biol. 3 2007 1909 1924
-
(2007)
PLoS Comput. Biol.
, vol.3
, pp. 1909-1924
-
-
Marino, S.1
-
29
-
-
33646025858
-
Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection
-
D. Sud, and et al. Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection J. Immunol. 176 2006 4296 4314
-
(2006)
J. Immunol.
, vol.176
, pp. 4296-4314
-
-
Sud, D.1
-
30
-
-
84455169868
-
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions
-
M.C. Kjellsson, and et al. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions Antimicrob. Agents Chemother. 56 2012 446 457
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 446-457
-
-
Kjellsson, M.C.1
-
31
-
-
79954595692
-
High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions
-
B. Prideaux, and et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions Anal. Chem. 83 2011 2112 2118
-
(2011)
Anal. Chem.
, vol.83
, pp. 2112-2118
-
-
Prideaux, B.1
-
32
-
-
84881114100
-
Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model
-
R.S. Wallis, and et al. Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model PLoS ONE 8 2013 e71116
-
(2013)
PLoS ONE
, vol.8
, pp. e71116
-
-
Wallis, R.S.1
-
33
-
-
67649991190
-
Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs
-
S. Goutelle, and et al. Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs Antimicrob. Agents Chemother. 53 2009 2974 2981
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 2974-2981
-
-
Goutelle, S.1
-
34
-
-
33845580084
-
Mathematical modeling of chemotherapy of human TB infection
-
G. Magombedze, and et al. Mathematical modeling of chemotherapy of human TB infection J. Biol. Syst. 14 2006 509 553
-
(2006)
J. Biol. Syst.
, vol.14
, pp. 509-553
-
-
Magombedze, G.1
-
35
-
-
44449128516
-
Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption
-
J.J. Wilkins, and et al. Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption Antimicrob. Agents Chemother. 52 2008 2138 2148
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 2138-2148
-
-
Wilkins, J.J.1
-
36
-
-
71849100552
-
Advances in immunotherapy for tuberculosis treatment
-
ix
-
G.J. Churchyard, and et al. Advances in immunotherapy for tuberculosis treatment Clin. Chest Med. 30 2009 769 782 ix
-
(2009)
Clin. Chest Med.
, vol.30
, pp. 769-782
-
-
Churchyard, G.J.1
-
37
-
-
34447256528
-
Immunotherapeutics for tuberculosis in experimental animals: Is there a common pathway activated by effective protocols?
-
G.A. Rook, and et al. Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols? J. Infect. Dis. 196 2007 191 198
-
(2007)
J. Infect. Dis.
, vol.196
, pp. 191-198
-
-
Rook, G.A.1
-
38
-
-
21844433456
-
Reconsidering adjuvant immunotherapy for tuberculosis
-
R.S. Wallis Reconsidering adjuvant immunotherapy for tuberculosis Clin. Infect. Dis. 41 2005 201 208
-
(2005)
Clin. Infect. Dis.
, vol.41
, pp. 201-208
-
-
Wallis, R.S.1
|